These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

614 related articles for article (PubMed ID: 9596892)

  • 1. [A clinical analysis of 153 uterine sarcomas].
    Bai P; Sun J; Chao H
    Zhonghua Fu Chan Ke Za Zhi; 1997 Mar; 32(3):163-7. PubMed ID: 9596892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective analysis of 105 cases with uterine sarcoma.
    Yoney A; Eren B; Eskici S; Salman A; Unsal M
    Bull Cancer; 2008 Mar; 95(3):E10-7. PubMed ID: 18390406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome.
    Callister M; Ramondetta LM; Jhingran A; Burke TW; Eifel PJ
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):786-96. PubMed ID: 14967435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: experience in Helsinki University Central Hospital 1990-2001.
    Koivisto-Korander R; Butzow R; Koivisto AM; Leminen A
    Gynecol Oncol; 2008 Oct; 111(1):74-81. PubMed ID: 18657852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uterine leiomyosarcoma: analysis of treatment failures and survival.
    Gadducci A; Landoni F; Sartori E; Zola P; Maggino T; Lissoni A; Bazzurini L; Arisio R; Romagnolo C; Cristofani R
    Gynecol Oncol; 1996 Jul; 62(1):25-32. PubMed ID: 8690287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Uterine sarcomas: clinical and histopathological aspects. Report on 15 cases].
    Leung F; Terzibachian JJ; Aouar Z; Govyadovskiy A; Lassabe C
    Gynecol Obstet Fertil; 2008 Jun; 36(6):628-35. PubMed ID: 18538624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma.
    Pautier P; Genestie C; Rey A; Morice P; Roche B; Lhommé C; Haie-Meder C; Duvillard P
    Cancer; 2000 Mar; 88(6):1425-31. PubMed ID: 10717626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Malignant mesodermal mixed tumor of the uterus--a study of 37 cases].
    Zhang WH
    Zhonghua Zhong Liu Za Zhi; 1991 Sep; 13(5):378-80. PubMed ID: 1664319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic pelvic irradiation as part of primary therapy in uterine sarcomas.
    Sorbe B; Johansson B
    Int J Oncol; 2008 May; 32(5):1111-7. PubMed ID: 18425339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Purely mesenchymal homologous uterus sarcomas (leiomyosarcomas and endometrial stroma sarcomas) at the Zurich University Gynecologic Hospital].
    Bronz L; Genton CY; Kunz J; Schreiner WE
    Geburtshilfe Frauenheilkd; 1985 May; 45(5):288-93. PubMed ID: 4007466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of aggressive histologic variants of endometrial carcinoma at the Tom Baker Cancer Centre between 1984 and 1994.
    Craighead PS; Sait K; Stuart GC; Arthur K; Nation J; Duggan M; Guo D
    Gynecol Oncol; 2000 May; 77(2):248-53. PubMed ID: 10785473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limitations of adjuvant radiotherapy for uterine sarcomas spread beyond the uterus.
    Dusenbery KE; Potish RA; Judson P
    Gynecol Oncol; 2004 Jul; 94(1):191-6. PubMed ID: 15262141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Radiotherapy in the treatment of uterine sarcomas].
    Bai P; Sun J
    Zhonghua Fu Chan Ke Za Zhi; 2001 Mar; 36(3):159-61. PubMed ID: 11783393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survival.
    Krivak TC; Seidman JD; McBroom JW; MacKoul PJ; Aye LM; Rose GS
    Gynecol Oncol; 2001 Oct; 83(1):89-94. PubMed ID: 11585418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognoses and prognostic factors of carcinosarcoma, endometrial stromal sarcoma and uterine leiomyosarcoma: a comparison with uterine endometrial adenocarcinoma.
    Akahira J; Tokunaga H; Toyoshima M; Takano T; Nagase S; Yoshinaga K; Tase T; Wada Y; Ito K; Niikura H; Yamada H; Sato A; Sasano H; Yaegashi N
    Oncology; 2006; 71(5-6):333-40. PubMed ID: 17690557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874).
    Reed NS; Mangioni C; Malmström H; Scarfone G; Poveda A; Pecorelli S; Tateo S; Franchi M; Jobsen JJ; Coens C; Teodorovic I; Vergote I; Vermorken JB;
    Eur J Cancer; 2008 Apr; 44(6):808-18. PubMed ID: 18378136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidemiological factors, treatment and prognosis of uterine sarcomas: 14 cases at the Cancer Institute of Dakar].
    Dem A; Kasse AA; Diop M; Cisse B; Toure P
    Dakar Med; 2000; 45(1):85-8. PubMed ID: 14666799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment, results and prognostic factors in stage I and II sarcomas of the corpus uteri.
    Vongtama V; Karlen JR; Piver SM; Tsukada Y; Moore RH
    AJR Am J Roentgenol; 1976 Jan; 126(1):139-47. PubMed ID: 175673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors and outcome in women with uterine sarcoma.
    Denschlag D; Masoud I; Stanimir G; Gilbert L
    Eur J Surg Oncol; 2007 Feb; 33(1):91-5. PubMed ID: 17174517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uterine sarcomas: the Curie Institut experience. Prognosis factors and adjuvant treatments.
    Chauveinc L; Deniaud E; Plancher C; Sastre X; Amsani F; de la Rochefordiere A; Rozemberg H; Clough KB
    Gynecol Oncol; 1999 Feb; 72(2):232-7. PubMed ID: 10021306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.